Endocrine disorders and metabolic diseases are often quite complex and typically involve the regulation of various body functions. Charles River’s expertise in this therapeutic area includes the progression and analysis of compounds and agents targeting a wide range of conditions, including diabetes, obesity, bone disease, thyroid disease, metabolic disorders, cholesterol and lipid disorders, among several others. Basic Research Metabolism and Regulation Research Models Customized Animal Models Discovery Biomarker Services Drug Discovery Antidiabetic Drug Efficacy Studies Contract Pharmacology Studies in Established Diet–Induced Obesity Model Biomarker & Analytical Services Safety Assessment Bone Research Toxicology Studies Drug Metabolism and Pharmacokinetics Lab Sciences Clinical Support Clinical Bioanalysis Clinical Pharmacokinetics Clinical Immunology and Biomarker Services Pathology for Clinical Trials Manufacturing Support GMP-Compliant Biopharmaceutical Manufacturing Endotoxin Detection and Microbial Identification